Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution-Reference-Cited by-同舟云学术

Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution

Published:2019-03 Issue:3 Volume:25 Page:577-586
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Melendez-Munoz Ricardo,Marchalik Rachel,Jerussi Theresa,Dimitrova Dimana,Nussenblatt Veronique,Beri Andrea,Rai Khalid,Wilder Jennifer S.,Barrett A. John,Battiwalla Minoo,Childs Richard W.,Fitzhugh Courtney D.,Fowler Daniel H.,Fry Terry J.,Gress Ronald E.,Hsieh Matthew M.^ORCID,Ito Sawa,Kang Elizabeth M.,Pavletic Steven Z.,Shah Nirali N.,Tisdale John F.,Gea-Banacloche Juan,Kanakry Christopher G.,Kanakry Jennifer A.

Funder

NIH

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis;Crocchiolo;Transpl Infect Dis,2015

2. Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults;Illiaquer;J Clin Virol,2017

3. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation;Styczynski;Infect Dis Ther,2018

4. Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation;Camargo;Hematol Oncol Stem Cell Ther,2017

5. How we treat cytomegalovirus in hematopoietic cell transplant recipients;Boeckh;Blood,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus in haematopoietic cell transplantation - The troll is still there;Best Practice & Research Clinical Haematology;2024-09

2. Clinical characteristics and outcomes of immunocompromised critically ill patients with cytomegalovirus end-organ disease: a multicenter retrospective cohort study;Critical Care;2024-07-16

3. Comparative analysis of the impact of cytomegalovirus viremia between fully matched and haploidentical hematopoietic stem cell transplants in acute leukemia patients;The Egyptian Journal of Haematology;2024-04

4. Oral Versus Intravenous Anti-CMV Preemptive Strategies in Allogeneic Stem Cell Transplant Patients with CMV Reactivation: Experience from the National Center of Bone Marrow Transplantation, Tunis, Tunisia;OBM Transplantation;2023-09-12

5. Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia;Annals of Hematology;2023-07-13